Danaher Corporation $DHR Shares Acquired by Broderick Brian C

Broderick Brian C grew its position in shares of Danaher Corporation (NYSE:DHR) by 4.4% in the 1st quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 65,605 shares of the conglomerate’s stock after purchasing an additional 2,794 shares during the quarter. Danaher makes up about 2.3% of Broderick Brian C’s portfolio, making the stock its 16th biggest holding. Broderick Brian C’s holdings in Danaher were worth $12,439,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in DHR. Main Street Group LTD purchased a new position in Danaher in the first quarter valued at $25,000. JPL Wealth Management LLC purchased a new stake in shares of Danaher during the 3rd quarter worth about $25,000. Elevated Capital Advisors LLC purchased a new stake in shares of Danaher during the 4th quarter worth about $26,000. WFA of San Diego LLC acquired a new stake in shares of Danaher during the 2nd quarter valued at about $26,000. Finally, Hilton Head Capital Partners LLC acquired a new stake in shares of Danaher during the 4th quarter valued at about $27,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Danaher Stock Down 0.1%

DHR stock opened at $203.65 on Monday. Danaher Corporation has a 52 week low of $160.93 and a 52 week high of $242.80. The company has a quick ratio of 1.52, a current ratio of 1.87 and a debt-to-equity ratio of 0.33. The firm has a 50-day simple moving average of $183.27 and a 200-day simple moving average of $198.25. The stock has a market capitalization of $144.14 billion, a P/E ratio of 39.39, a P/E/G ratio of 2.51 and a beta of 0.79.

Danaher (NYSE:DHR) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share for the quarter, beating analysts’ consensus estimates of $1.94 by $0.12. Danaher had a net margin of 14.89% and a return on equity of 10.91%. The firm had revenue of $5.95 billion for the quarter, compared to analyst estimates of $6 billion. During the same period last year, the company posted $1.88 EPS. Danaher’s quarterly revenue was up 3.7% compared to the same quarter last year. Equities analysts forecast that Danaher Corporation will post 8.45 earnings per share for the current fiscal year.

Danaher Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date is Friday, June 26th. Danaher’s dividend payout ratio (DPR) is 30.95%.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of analyst reports. The Goldman Sachs Group reduced their price target on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. JPMorgan Chase & Co. dropped their price objective on Danaher from $275.00 to $245.00 and set an “overweight” rating on the stock in a report on Wednesday, April 22nd. Evercore restated an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. UBS Group reduced their target price on Danaher from $270.00 to $250.00 and set a “buy” rating for the company in a research note on Wednesday, April 22nd. Finally, Wall Street Zen lowered Danaher from a “buy” rating to a “hold” rating in a research report on Saturday, April 25th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and five have given a Hold rating to the company’s stock. According to MarketBeat.com, Danaher presently has an average rating of “Moderate Buy” and an average target price of $231.64.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.